BioSpace News Archive

Drug Development

RG6501 (OpRegen®) Preclinical Engraftment Results to Be Presented at 2024 Association for Research in Vision and Ophthalmology Meeting

Lineage Cell Therapeutics, Inc. today announced that preclinical results as part of a surgical development study evaluating the survival and distribution of RG6501.

March 11, 2024
·
6 min read
InnoGI Technologies Awarded Contract to Provide tiny-TIMsg Mimicking Human GUT (SurroGUT™) to U.S. Food and Drug Administration for Advanced Drug Absorption Research

InnoGI Technologies, formerly The TIM Company, announced today that The U.S. Food and Drug Administration (FDA) acquired a tiny-TIMsg System.

March 11, 2024
·
5 min read
Deals

Merck Completes Acquisition of Harpoon Therapeutics, Inc.

Merck today announced the completion of the acquisition of Harpoon Therapeutics, Inc. (Nasdaq: HARP).

March 11, 2024
·
5 min read
Genetown

bluebird bio Announces First Outcomes-Based Agreement with Medicaid for Sickle Cell Disease Gene Therapy

bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird bio”) today announced it has signed its first Medicaid outcomes-based agreement for LYFGENIA.

March 11, 2024
·
12 min read
Biotech Bay

Alumis to Participate in the 2024 Leerink Partners Global Biopharma Conference

Alumis Inc. today announced that Company management will host investor meetings at the 2024 Leerink Partners Global Biopharma Conference on March 12, 2024, in Miami, Florida.

March 11, 2024
·
1 min read
Genetown

Akston Biosciences’ AKS-107 Study Published in Frontiers in Immunology, Displaying Ambifect® Platform’s Versatility

Akston Biosciences’ AKS-107 Study Published in Frontiers in Immunology , Displaying Ambifect ® Platform’s Versatility.

March 11, 2024
·
3 min read
DiagnaMed Accelerates Commercialization Initiatives of CERVAI™ Brain Health AI Solution

DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF) is pleased to announce that it has been accepted into the Hamilton Ecosystem to Accelerate and Leverage Trials of Health Innovation (“HEALTHI”) program to accelerate the clinical research and commercialization efforts in Canada for the Company’s CERVAI™ Brain Health AI Platform.

March 11, 2024
·
5 min read
FDA

FDA Grants Orphan Drug and Pediatric Exclusivities for CRESEMBA® (isavuconazonium sulfate) for Invasive Aspergillosis and Invasive Mucormycosis in Children

Astellas Pharma US, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug and pediatric exclusivity to CRESEMBA® (isavuconazonium sulfate) for the treatment of invasive aspergillosis (IA) and invasive mucormycosis (IM) in pediatric patients.

March 11, 2024
·
9 min read
Lunit Expands AI Medical Imaging Solutions in East & Southeast Asia: Partners with Chung Shan Medical University and Gleneagles Hospital Singapore

Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced two supply contracts that mark its strategic expansion into the East and Southeast Asian region.

March 11, 2024
·
3 min read
Business

Cadrenal Therapeutics Provides Fourth Quarter 2023 Corporate Update

Cadrenal Therapeutics, Inc. today provided a corporate update in connection with the filing of its Annual Report on Form 10-K for the year ended December 31, 2023.

March 11, 2024
·
7 min read